Dr. Michelle Lynn Mauermann, MD

Dr. Mauermann practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Mauermann's NPI, 1447277348, was assigned on July 16, 2006. Dr. Mauermann graduated from Carver College of Medicine in 2002. Dr. Mauermann holds Minnesota license 48968.

Dr. Mauermann's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Mauermann's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Mauermann to 1 more hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mauermann practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Mauermann's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Mauermann is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Mauermann is licensed in Minnesota.

Dmand AI lists fibromyalgia and chronic pain, hereditary polyneuropathy and neuropathy among the conditions Dr. Mauermann treats.

CMS data shows 805 Medicare services from Dr. Mauermann across 13 procedure codes in 2024, for 355 Medicare patients. Medicare paid $72,416 for them. Every service was in an office.

CMS counts 355 Medicare patients who saw Dr. Mauermann in 2024. The largest group is 65 to 74, with 189 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mauermann's median patient age at 63, with 52% women.

In 2024, Dr. Mauermann wrote 34 Medicare Part D claims. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $160,658 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Mauermann accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 153 papers to Dr. Mauermann, published from 2009 to 2025. 2021 was the busiest year, with 14. The most frequent topics are Magnetic Resonance Imaging, Neural Conduction and Peripheral Nervous System Diseases. Dr. Mauermann has published most often in Neurology. Dr. Mauermann's most frequent co-authors are Christopher J. Klein, MD, P. James B. Dyck, MD and Robert J. Spinner, MD.

CMS Open Payments shows 3 general payments to Dr. Mauermann from 2 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 94% of the total. Alnylam Pharmaceuticals Inc. paid the most, $2,584.

Dmand AI lists 11 awards for Dr. Mauermann, most recently Top Educator Award in 2011.

Dr. Mauermann graduated from Carver College of Medicine in 2002.

Dr. Mauermann is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.